Neonatal HSV Infection: Classification, Risk Factors, and Urgent Management

Neonatal herpes simplex virus (HSV) infection is a medical emergency with high morbidity/mortality if untreated. Acquisition is primarily peripartum (vertical transmission).

Classification (Clinical Syndromes)

Risk Factors for Transmission

  • Maternal Primary HSV (1st/2nd trimester): ~30–50% transmission risk; highest if acquired in 3rd trimester (no maternal antibodies).
  • Maternal Recurrent HSV: ~1–3% transmission; antibodies partially protective.
  • Prematurity / Low Birth Weight: Immature skin/mucosal barrier, reduced IgG transfer.
  • Prolonged Rupture of Membranes, Fetal Scalp Electrodes: Increase exposure.

Diagnosis

  • PCR for HSV DNA: CSF (CNS), blood (disseminated), surface swabs (SEM).
  • Viral culture (less sensitive).
  • CSF: pleocytosis, elevated protein, normal/low glucose.
  • LFTs, CBC, coagulation panel for disseminated disease.

Treatment (Start Empirically if High Suspicion)

  • IV Acyclovir 20 mg/kg/dose q8h:
    • SEM: 14 days
    • CNS: 21 days
    • Disseminated: 21 days
  • Supportive: Seizure control, respiratory/circulatory support, nutrition.
  • Repeat CSF PCR at end of CNS/disseminated course; extend if positive.

Prevention

  • Suppressive acyclovir/valacyclovir from 36 weeks in women with recurrent HSV.
  • Cesarean delivery if active lesions/prodrome at labor onset.
  • Avoid fetal scalp electrodes if maternal HSV history.

Early IV acyclovir dramatically improves survival and neurodevelopmental outcomes. High index of suspicion is critical.

Baby Health - Related Articles

Health Sciences © https://www.222health.com

SyndromeFrequencyFeaturesMortality (Untreated)
Skin, Eye, Mouth (SEM)~45%Vesicles on skin, conjunctivitis, oral mucosa; no CNS/visceral involvement~0%
Central Nervous System (CNS)~30%Seizures, lethargy, irritability, poor feeding, CSF pleocytosis; ± skin lesions~50%
Disseminated~25%Multiorgan: hepatitis, pneumonitis, coagulopathy (DIC), encephalitis; ± skin lesions~85%